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CHARACTERIZING SELF-INSERTING CARBON-FIBER MICROELECTRODE ARRAYS
FOR FAST-SCAN CYCLIC VOLTAMMETRY

BRAD M. SMITH
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The ability to monitor brain neurotransmitters with high fidelity is critical for establishing
the neural underpinnings of behavior and pathology. Fast-scan cyclic voltammetry (FSCV) is an
electroanalytical technique that relies on sweeping electrical potentials to drive rapid oxidation and
reduction of electroactive neurochemicals. FSCV applications are typically limited by their ability
to measure from one to two recording sites using a well-established microsensor, the carbon-fiber
microelectrode (CFM). When coupled to FSCV, the CFM provides exquisite spatial, temporal,
and chemical resolution in vivo. Recent advances have led to the development of self-inserting
(i.e., without the requirement for a shuttle) carbon-fiber microelectrode arrays (CF-MEAs) capable
of measuring up to sixteen sites simultaneously. Here we characterize CF-MEAs for measuring
dopamine (DA), a neurotransmitter critical for locomotion, motivation, and cognition that also
plays a substantive role in the pathologies of Parkinson’s disease, substance use disorder, and
schizophrenia. In general, performance of CF-MEAs for FSCV DA monitoring assessed with flow
injection analysis, a “beaker” technique that directs a laminar bolus of dopamine to the sensing
surface, compared favorably with those of the conventional CFM. Measurements in the urethaneanesthetized rat also suggest that CF-MEAs are capable of capturing heterogeneous DA signals in
the striatum, a brain region densely innervated by DA neurons and heavily implicated in reward
learning, with high fidelity to conventional CFMs but simultaneously at multiple sites across a

much broader measurement field. We conclude that CF-MEAs perform favorably in comparison
to CFMs with regard to temporal response, DA sensitivity, background signal, signal-to-noise
ratio, and peak oxidative potential. Moreover, CF-MEAs have a distinct advantage over CFMs to
characterize the heterogeneous nature of DA signaling in vivo through their ability to
simultaneously monitor a 1.5 mm mediolateral span of the brain in 100-μm increments.

KEYWORDS: carbon fiber microelectrode (CFM); carbon fiber microelectrode array (CF-MEA);
flow injection analysis (FIA); dopamine (DA); fast-scan cyclic voltammetry (FSCV);
amphetamine (AMPH)
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CHAPTER I: INTRODUCTION
Monitoring neurotransmitters in the brain is crucial for establishing the neural
underpinnings of behavior and pathology. Although several techniques have been developed for
this purpose, microdialysis and voltammetry have arguably dominated the modern era of
neurochemical measurements (Watson et al., 2006; Robinson et al., 2008; Sandberg and Garris,
2010). In microdialysis, a sample of extracellular fluid is physically removed by the probe for
external analysis with techniques such as high-performance liquid chromatography coupled to
electrochemical detection or gas chromatography-mass spectrometry, whereas analytes are
electrochemically measured directly at the implanted microsensor in situ in voltammetry. A
radically different analytical approach, genetically encoded indicators, has been more recently
developed and received considerable attention for its potential to further advance neurochemical
measurements (Lin and Schnitzer, 2016; Patriarchi et al., 2019; Jing et al., 2019; Sabatini and
Tiam, 2020; Yocky and Covey, 2020). In this scheme, analyte binding to a brain cell-expressed
indicator (e.g., based on a neurotransmitter receptor) alters fluorescence that is detected by fiber
photometry, one-photon microendoscopy, or two-photon microscopy.
Fast-scan cyclic voltammetry (FSCV) at a carbon-fiber microelectrode (CFM) has long
been considered the gold standard for real-time neurochemical measurements at a microsensor
(Venton and Cao, 2020; Puthongkham and Venton, 2020). Overall, FSCV at a CFM is noted for
its high temporal, chemical, and spatial resolution. Temporal resolution is provided by application
of a voltage scan every 100 ms, during which an analyte measurement occurs. Chemical resolution
is provided by the voltammogram, a profile of measured current versus applied that functions as a
chemical signature, collected during each scan. The CFM is also an excellent sensor for FSCV. Its
carbon surface is well suited for performing electrochemistry in the brain (Robinson et al., 2008),
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and its size (r=3.5 µm) provides cell-approximate spatial resolution with minimal tissue trauma
during implantation (Jaquins-Gerstl and Michael, 2015).
Another attractive analytical characteristic of FSCV at a CFM is versatility. Although most
work to date has focused on dopamine (DA), a neurotransmitter involved in motivation,
movement, and cognition (Schultz 2007), in the rat striatum, there have been exciting
developments establishing FSCV at a CFM for: (1) non-DA neurotransmitters (e.g., serotonin,
norepinephrine, epinephrine, histamine, octopamine, adenosine, nitric oxide, and neuropeptides),
as well as a variety of neurochemicals (e.g., hydrogen peroxide, ascorbic acid, uric acid, oxygen,
and pH); (2) non-striatal brain regions (e.g., amygdala, cortex, raphe nucleus, bed nucleus of the
stria terminalis, thalamus, substantia nigra pars reticulata and compacta, ventral tegmental area,
hippocampus, spinal cord, and median eminence); (3) non-rat animal models (e.g., European
starling, zebra finch, mouse, vole, Syrian hamster, guinea pig, monkey, human, lamprey, zebrafish,
fruit fly, and honey bee) (Garris et al., 1994; Rice et al., 1994; Gale and Perkel, 2006; Greco et al.,
2006; Robinson et al., 2008; Park and West, 2009; Huffman and Venton, 2009; Hashemi et al.,
2011; Chang et al., 2012; Glanowska et al., 2012; Fortin et al., 2015; Smith et al., 2015; Pyakurel
et al., 2016; Srejic et al., 2015; Resendez et al., 2016; Shin et al., 2017; Noga et al., 2017; Jarriault
et al., 2018; Roberts and Sombers, 2018; Saylor et al., 2019; Stagkourakis et al., 2019; Tan et al.,
2021). Versatility is also conferred because FSCV does not require the transgenic manipulation
(Patriarchi et al., 2018; Sun et al., 2018) or contrast agent infusions needed for other neurochemical
sensing techniques (Li and Hasanoff, 2020).
Because of different measurement strategies, microdialysis, FSCV at a CFM, and
genetically encoded indicators exhibit different analytical characteristics (Wang et al., 2018). In
general, microdialysis exhibits superior sensitivity and chemical resolution while FSCV at a CFM
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excels at temporal and spatial resolution. Two critical technical advancements have reduced the
performance gap between FSCV at a CFM and microdialysis. Sensitivity of FSCV has been
increased by extending the potential limits of the voltage scan to overoxidize the carbon surface
of the CFM and increase analyte adsorption (Heien et al., 2003). Chemical resolving power of
FSCV has been enhanced with a chemometrics approach called principal component regression
(PCR) (Heien et al., 2005; Keithley et al., 2009). These improvements have led to the detection of
behaviorally relevant sub-second to second DA signals called transients (Day et al., 2007) and
more slowly occurring alterations in basal DA levels (Howe et al., 2013) measured in units of
concentration change relative to a zeroed background. Moreover, absolute concentrations of basal
DA have now been measured using a CFM with alternative waveforms such as fast-scan
adsorption-controlled voltammetry (Atcherley et al., 2013, 2015) and fast-cyclic square-wave
voltammetry (Park et al., 2018; Oh et al., 2018).
Although direct quantitative comparisons are not yet available, the DA-receptor based
indicators of GRABDA and dLight (Patriarchi et al., 2018; Sun et al., 2018) appear to exhibit
superior temporal and chemical resolution and sensitivity for DA measurements compared to
FSCV at a CFM. Comparisons of spatial resolution depend upon the scheme for fluorescent
detection. For example, the probe in fiber photometry is considerably larger than the CFM (>100
µm versus 8 µm in diameter, respectively). On the other hand, 2-photon microscopy can detect
DA release from a single DA fiber in a mouse striatal slice (Sun et al., 2018) and within 17-µm2
regions of interest in the cortex of an awake, head-fixed mouse (Patriarchi et al., 2018). Activity
of single DA neurons is also detected using the Ca2+ indicator GCaMP with 1-photon
microenodoscopy in a freely moving mouse, but a large (≈500 um) gradient index lens must be
implanted above the target region (da Silva et al., 2018). An exciting application of this approach
3

was monitoring the activity of the same DA neuron across days. Thus, while powerful, the
enhanced spatial resolution of genetically encoded indicators and the ability for longitudinal
measurements of the same neuron come with some restrictions. In contrast to FSCV at a CFM,
which can be calibrated pre- or post-experiment and even in situ (Schuweiler et al., 2018),
GRABDA and dLight measurements are not easily converted to concentration. Other limitations of
genetically encoded indicators are photobleaching, avoidance of pharmacological agents acting at
the DA receptor, and the requirement that the animal model is amenable to transgenic modification.
Both genetically encoded indicators and FSCV at a CFM exhibit a similar, somewhat restricted
capability for simultaneous multianalyte monitoring, which is considerably less than that for
microdialysis.
A CFM acutely implanted with a detachable micromanipulator was initially used for FSCV
measurements of DA in the freely moving rat (Garris et al., 1997). The subsequent development
of a chronically implantable CFM permitted longitudinal measurements at the same recording site
over months (Clark et al., 2010). Despite the profound impact of these technical advances on
investigations of DA-behavior relationships (e.g., Phillips et al., 2003; Day et al., 2007; Gan et al.,
2010; Flagel et al., 2011), the number of recording sites in a single animal was typically limited to
one or two. By contrast, fiber photometry with arrays (Guo et al., 2015) or distributed probes (Kim
et al., 2016) and subdivision of the viewing field into regions of interest in 2-photon microscopy
(Patriarchi et al., 2018; Sun et al., 2018) affords simultaneous neurochemical interrogation of
multiple sites. Guo et al. (2015) have performed three channel fiber photometry with success, but
the large diameter (~200 μm) of optical fibers makes recording with high spatial resolution
challenging.
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The well-established use of FSCV at a CFM has led to the development of multi-site arrays
that take advantage of the temporal and spatial resolving power of FSCV. While several multi-site
recording devices have been developed and tested, each has physical properties or technical
challenges that reduce their utility. One such example is a planar probe that employs pyrolyzed
photoresist electrodes (PPEs) (Zachek et al., 2009). While performance of PPEs was favorable in
in vitro characterization, relatively slow response time to DA as well as the overall size (~200 μm)
suggests that further work is needed prior to routine in vivo utilization. Carbon fiber multielectrode arrays (CF-MEAs) have been in development for over a decade, with multiple designs
performing favorably during characterization. Initial designs were utilized for electrophysiology
applications in the cortex (Patel et al., 2015). While this application required fiber lengths much
shorter than are necessary for midbrain measurements, the fragility of carbon fibers necessitated
use of structural support to facilitate insertion into the cortex. One way demonstrated to support
CF-MEA implantation was a single-width (≈30 x 24 µm), beveled-tip silicon support structure
that was successful for acute cortical electrophysiological recording. Alternatively, a
biodissolvable polyethylene glycol (PEG)-based substrate was used to facilitate fiber insertion
while maintaining the small diameter of the carbon fiber and supported chronic cortical
electrophysiology recording. This PEG-based insertion shuttle has applications for both FSCV and
electrophysiological measurements. Indeed, the use of PEG-based substrates has been used
successfully on CF-MEAs capable of FSCV measurements in the midbrain (Schwerdt et al., 2017;
Schwerdt et al., 2018), but dissolution of PEG can present technical challenges that complicate
insertion. To overcome the challenges associated with PEG-based substrates, engineers at
University of Michigan developed rectangular (~1.3 mm x 0.2 mm) guide cannulas for
implantation to protect CF-MEAs during placement (Patel et al., 2020). While the guide cannula
5

is highly effective in facilitating fiber insertion, its size leads to a significant level of tissue
disruption during insertion.
Here, in an effort to minimize tissue trauma caused by guide cannula insertion and to avoid
complications with PEG dissolution, we assess the performance of newly developed siliconsupported CF-MEAs for the purpose of obtaining DA measurements using FSCV in the striatum,
a deep subcortical structure. The silicon support structure is tapered from 55.5 to 15.5 µm
(thickness of ~20 µm), leaving 500 µm of only carbon fiber beyond the tip. The newly developed
CF-MEA was compared to the performance of the conventional CFM. Flow injection analysis
(FIA) was used to assess sensor temporal response, sensitivity, root-mean-square (RMS) noise,
total background current (TBC), and signal-to-noise ratio (SNR). Follow-up measurements using
a urethane-anesthetized rat model assessed the ability of CF-MEAs to monitor DA in the striatum
in vivo. DA signals, consisting of electrically evoked transient-like signals, changes in baseline
DA concentration, and phasic DA transients, were used to assess CF-MEA performance. The
conventional CFM has been widely used in brain slices and in vivo to monitor electrically,
optically, pharmacologically, and behaviorally-evoked DA signals for studies focusing on DA
neuroscience and pharmacology (Robinson et al., 2008; Sandberg and Garris, 2010; Puthongkham
and Venton, 2020). Thus, performance was not only characterized in terms of consistency between
sites of CF-MEAs and between CF-MEAs of the same type but also in terms of differences
between CF-MEAs and CFMs. Based on our analysis of in vitro and in vivo data, we conclude that
silicon-supported CF-MEAs perform favorably in comparison to CFMs with regard to temporal
response, DA sensitivity, background signal, SNR, and peak oxidative potential of DA. Moreover,
silicon-supported CF-MEAs are shown to have a distinct advantage over CFMs to characterize the
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heterogeneous nature of DA signaling in the striatum in vivo through their ability to simultaneously
monitor a 1.5 mm mediolateral span of the dorsal striatum in 100-μm increments.
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CHAPTER II: METHODS
Animals
Adult male Sprague-Dawley rats (300-350g) were purchased from Envigo (Indianapolis,
IN, USA) and housed in the temperature-controlled Felmley Science Annex with a 12-hour
light/dark cycle. Food and water was provided ad libitum. All procedures were carried out in
accordance with protocols approved by the Illinois State University Institutional Animal Care and
Use Committee (IACUC).
Sensors
CFMs (Fig. 1A, far left) were constructed by aspirating an individual carbon fiber (7-μm
diameter, Cytec Engineering Materials, West Patterson, NJ, USA) into a borosilicate capillary tube
(1.2 mm outer diameter, 0.8 mm inner diameter, Sutter Instrument, Novato, CA, USA) and pulled
using a vertical micropipette puller (Narishige, Tokyo, Japan). After separation, the distal end of
the capillary tube was fractured to create an opening of ~20 μm in diameter. The capillary was
sealed with epoxy (Miller-Stephenson Chemical, Morton Grove, IL USA) and allowed to cure at
room temperature for 72 hours. The carbon fiber was then trimmed to a length of 50 μm beyond
the epoxy seal, and electrical connection between the carbon fiber and lead wire was established
by inserting and melting a small piece of bismuth alloy (Small Parts, Inc., Miramar, FL, USA)
with a heat gun (Master Appliance Corp., Racine, WI, USA).
Both 8-site and 16-site CF-MEAs (Fig. 1A) were provided by the Chestek Lab (University
of Michigan, Ann Arbor, MI, USA). The CF-MEAs used in this study are custom fabricated selfinsertable devices designed to measure both electrophysiological and neurochemical signals. To
briefly summarize the manufacturing process, printed circuit boards are manufactured with either
8 or 16 traces/trenches to accommodate electrical connection of individual carbon fibers.
8

Individual carbon fibers are coated with the insulation Parylene C and reinforced by a silicon shank
that decreases in diameter stepwise toward the exposed carbon-fiber tip (Fig. 1A INSETS). Laser
ablation of the Parylene C re-exposes and increases the surface area of 50 μm of carbon fiber, the
same length of fiber exposed on traditional CFMs, and oxygen plasma ashing is performed to
maximize surface area. Additional CF-MEA fabrication details and software specifications can be
found in Patel et al. (2015) and Patel et al. (2020).
Fast-Scan Cyclic Voltammetry
FSCV is recorded by scanning a triangular waveform (400 V/s) from -0.4 V to +1.3 V at a
sampling rate of 10 Hz. The sensing surface is held at -0.4 V between scans. Applied potentials
are referenced to an Ag/AgCl electrode, constructed from chloridizing the exposed tip of a Tefloncoated silver wire (Stoelting, Wood Dale, IL, USA). Both CFMs and CF-MEAs are connected to
a headstage (Fig. 1A), which is routed via a lead cable (Fig. 1B) to a breakout box (Fig. 1C). The
breakout box interfaces between the headstage and two PCIe-7841 data acquisition boards
(National Instruments, Austin, TX, USA) installed in a PC computer and is powered by a
standalone power supply (BK Precision, Yorba Linda, CA, USA; Fig. 1D). All data are collected
using the LabView-based (National Instruments, Austin, TX, USA) Wolverine FSCV program
(Chestek Lab, University of Michigan, Ann Arbor, MI, USA) and analyzed using HDCV
(University of North Carolina, Chapel Hill, NC, USA).
Flow Injection Analysis
The FIA flow cell (Fig. 2) (Rheodyne, Rohnert Park, CA, USA) operates using a nitrogendriven pneumatic actuator that is triggered by a user-defined transistor-transistor logic (TTL)
square wave pulse generated in the Wolverine FSCV data acquisition program (Chestek Lab,
University of Michigan, Ann Arbor, MI, USA). Tris buffer is continuously pumped into a custom9

built flow cell reservoir using a syringe pump (Harvard Apparatus, Cambridge, MA, USA) at a
rate of 240 mL/min. DA solution is pre-loaded into an injection loop and is delivered as a bolus in
the flow stream during a user-defined period when triggered by the TTL pulse. The bolus of
known-concentration analyte allows for extensive analysis of performance of both CFMs and CFMEAs.
Surgery
Rats were anesthetized using urethane (Acros Organics, Geel, Belgium) dissolved in 0.9%
(150 mM) normal saline (1.6 g/kg i.p.) and subsequently immobilized in a stereotaxic frame (David
Kopf Instruments, Tujunga, CA, USA). A linear incision was made in the scalp to expose the skull,
and burr holes were drilled with a high-speed rotary tool (Foredom, Bethel, CT, USA) based on
anatomical reference points (Paxinos and Watson, 1986) to accommodate placement of the
stimulating electrode (AP -4.6, ML +1.3, DV -8.0 relative to bregma), reference electrode
(contralateral superficial cortex), and sensors (AP +1.2, ML +1.5, DV -4.0 and AP +1.2, ML +3.0,
DV -4.0, both relative to bregma). Computer-generated electrical stimulation was passed through
an optical isolator and constant-current generator (Digitimer Limited, Letchworth Garden City,
United Kingdom). Stimulation pulses were applied to a twisted bipolar electrode (Plastics One,
Roanoke, VA, USA), with tips polished and separated by 1 mm. Dorsoventral depth of the
stimulating electrode optimized atop the medial forebrain bundle until robust electrically evoked
DA release was observed at a single CFM. Stimulus trains consisted of biphasic pulses (2 ms for
each phase) delivered at an intensity of ±300 µA, a frequency of 60 Hz, and a duration ranging
from 0.4 s (24 pulses) to 3 s (180 pulses). Stimulus parameters were selected to elicit DA signals
comparable in dynamics and amplitude to DA transients (Robinson and Wightman, 2007). In
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experiments requiring intravenous (i.v.) administration of drugs, venous access was established
via cutdown and direct visualization of the femoral vein to ensure i.v. patency.
Data Analysis
Cyclic voltammograms were filtered in HDCV using a lowpass Bessel setting. Temporal
response of sensors was recorded as the amount of time from baseline to 85% of normalized
maximal current observed during FIA injections. Sensitivity (nA/ μM DA) was determined by
exposing sensors to DA boluses at varying concentrations and calculating the resulting slope of a
linear regression curve. Root-mean-square (RMS) noise was calculated using current tracings
taken at the peak oxidative potential for DA in ten consecutive measurements at the beginning of
FSCV recordings. Total background current (TBC) was calculated by summing the absolute value
current of all 1,000 data points in the cyclic voltammogram at the beginning of FSCV recordings.
Finally, signal-to-noise ratio (SNR) was calculated by dividing signal maximal current by RMS
noise.
Background subtraction for in vivo electrically evoked transient-like signal analysis
occurred by averaging ten cyclic voltammograms at the beginning of recordings. Background
subtraction for in vivo non-evoked signal analysis occurred by averaging ten cyclic
voltammograms immediately prior to the observed event. Training set data was captured in HDCV,
and principle component regression (PCR), a chemometrics approach combining principle
component analysis and inverse least-squares regression, was utilized to quantify changes in DA
concentration and isolate the effects of change in pH and baseline drift. Principle component
regression output was considered valid when Q scores did not exceed Qα as calculated by HDCV.
Hangup, defined as adsorption of DA to the sensing surface, was removed and data were fit to the
3-parameter restricted diffusion model of Michael and co-workers (Walters et al., 2015):
11

dDAic
= 𝑅p 𝑓 − DAic 𝑘T
d𝑡

(1)

d[DA]oc DAic 𝑘T
=
− [DA]oc 𝑘U
d𝑡
𝑉oc

(2)

where DAic is the amount of DA (in moles) in the inner compartment, Rp is the moles of DA
released per stimulus pulse, f is the stimulus frequency, kT is a first-order rate constant for DA
transport from inner to outer compartment, Voc is the volume of the outer compartment, kU is the
first-order rate constant for DA uptake, and [DA]oc is the concentration of DA in the outer
compartment. The simulated response was calculated from fitted parameters for Rp, kT, and kU.
Non-evoked DA signals were analyzed using MiniAnalysis (Synaptosoft, Decatur, GA, USA).
Non-evoked signals with a SNR of greater than five times RMS noise were identified as DA
transients.
Evoked signal types were identified in the method of Taylor et al. (2015). These electrically
evoked signals (180 p, 60 Hz, ±300 μA) include both fast (types 1, 2, 3, and 4) and slow responses.
Type I signals increase in a linear duration for the entire duration of the 3-s stimulation, and type
II signals increase for the duration of the 3-s stimulation but do so in a non-linear fashion. Type
III signals (not observed in this study) reach a maximal change in current prior to the end of the
stimulation, and type IV signals increase in a biphasic fashion for the entire duration of the
stimulation. A signal was considered a slow response if it failed to reach detection limit within 200
ms of the onset of the stimulation.
Statistics
FIA data was collected in replicates of three. Data was analyzed using one-way nested
ANOVA (CF-MEA-8s and CF-MEA-16s) and one-way ANOVA (CFMs and between sensor
12

type) to examine the characteristics both within and between sensor types. Post-hoc TukeyKramer analysis allowed for determination of which sites or sensors differed significantly.
Fidelity of PCR-resolved FIA data was assessed using a Pearson correlation coefficient. In vivo
kinetic parameters pre- and post-drug were compared with a paired t-test. All statistical tests
utilized a significance value of p=0.05.
Chemicals
To determine analyte response characteristics via FIA, a 5-mM DA stock solution was
created by dissolving DA hydrochloride (Sigma-Aldrich, St. Louis, MO, USA) in a 0.15 M
perchloric acid solution. The resulting solution was protected from light and stored at 4⁰ C until
and between use. A modified Tris buffer was utilized during all FIA measurements and consisted
of 15 mM Tris, 140 mM NaCl, 3.25 mM KCl, 1.2 mM CaCl2, 1.25 mM NaH2PO4, 1.2 mM MgCl2,
and 2.0 mM Na2SO4 in nanopure water brought to a physiologic pH of 7.4 with a small quantity
of NaOH. The Tris buffer was stored at 4⁰ C when not in use and was brought to room temperature
prior to data collection. 0.25-, 0.5-, 0.75-, and 1.0-μM DA solutions were created by micropipetting
aliquots of 5 mM DA stock solution into 50 mL of prepared Tris buffer measured in a volumetric
flask. pH 6.9, 7.15, 7.65, and 7.90 buffer was made by adding small quantities of hydrochloric
acid or sodium hydroxide. DA-containing solutions used for analysis were protected from light
and replaced every 30 minutes to mitigate the effects of DA degradation at room temperature.
Drugs
D-amphetamine hemisulfate (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in 0.9% normal
saline and administered via i.v. (1 mg/kg) or i.p (10 mg/kg). Raclopride tartrate (Sigma-Aldrich,
St. Louis, MO, USA) was administered 2 mg/kg i.p in a cocktail with D-amphetamine hemisulfate.
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CHAPTER III: RESULTS - CHARACTERIZATION OF CF-MEAs WITH FLOW INJECTION
ANALYSIS
Sensor Positioning
In conventional FIA, a CFM is centered in a flowing stream of buffer at the interface
between the tubing outlet and buffer reservoir of the flow cell to record the fastest response to the
analyte bolus (Fig. 3, top right). The initial response of a CFM to a 5-s DA bolus is fastest in the
outlet center (1.2 mm diameter), but appreciably slower when the sensor is positioned more
laterally as a result of both laminar flow and drag, i.e. both friction between fluid layers and friction
between fluid and the tubing wall. The overall width of the CF-MEAs creates limitations regarding
placement within the outlet. While the width of the 8-site CF-MEA (CF-MEA-8; 1.12 mm; Fig.
3, middle right) can be positioned within the 1.2 mm diameter of the tubing outlet, the width of
the 16-site CF-MEA (CF-MEA-16; 1.5 mm; Fig. 3, bottom right) exceeds FIA tubing diameter
and leads to concern over potential damage of lateral recording sites. Because the CF-MEA-8 can
safely be positioned at the flow injection interface, this sensor type was used to determine a height
above the outlet that provided a similar temporal response as the interface (Fig. 4A-H). Fig. 4A
demonstrates the positioning of the CF-MEA-8 above the tubing outlet in the flow injection
apparatus, with channels 4 and 5 closest to the center of the tubing outlet. The CF-MEA-8 was
moved dorsally in 0.5-mm increments from 0.0-mm (Fig. 4B) to +2.5-mm above the tubing outlet
(Fig. 4G) to determine the effect of distance from the tubing outlet on temporal response to the
DA bolus. While all distances tested reached 85% maximal current within 500 ms, a 1-mm height
above the interface demonstrated the fastest temporal response (300 ms to 85% maximal current,
Fig. 4H) and was used for all subsequent sensor response times in this study. Temporal responses
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were normalized to maximal current to characterize response time. Absolute current was used for
all other analyses.
The effects of laminar flow and drag based on lateral sensor position are demonstrated in
the CFM and CF-MEA-16 in Fig. 5. Sensor placement is depicted in Fig. 5A (top), and the leading
edge of the bolus is equivalently recorded when the CFM and central site of a CF-MEA-16 are
positioned at similar locations (Fig. 5A, middle and INSET). Background-subtracted
voltammograms recorded by FSCV for both sensors are shown underneath the temporal responses,
either serially in the pseudocolor plot or individually as a cyclic voltammogram (Fig. 5A, bottom).
With an oxidative peak ≈+0.6 V and a reductive peak ≈-0.2 V, voltammograms are characteristic
for DA. Figure 5B compares sequential responses recorded when the center site of a CF-MEA-16
was positioned at 100-µm increments across the tubing outlet (left) versus responses recorded
equivalently but simultaneously at each site of the CF-MEA-16, which are also spaced 100-µm
apart (right). In both sets of measurements, effects of laminar flow and drag on the DA bolus is
evident at 100-µm spatial resolution. A CF-MEA-8 exhibited comparable responses to laminar
flow and drag of the DA bolus (Fig. 4I, J, and K, top) and also recorded voltammograms
characteristic for DA (Fig. 4K, bottom).
Recording of similar dynamics of the DA bolus by the same CF-MEA site incrementally
positioned across the outlet and all CF-MEA sites simultaneously demonstrates that individual site
response is more related to position in the measurement field than array. This finding is critical
for attributing CF-MEA brain recordings of DA signals with different temporal responses to neural
origins (vide infra).
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Performance Metrics
Several analytical characteristics of DA measurements were assessed with FIA to compare
the performance of the CFM, CF-MEA-8, and CF-MEA-16 and are depicted in Figures 6-14. A
5-s bolus of 1-µM DA was recorded 1 mm above the tubing outlet (see Figs. 4A and 5A) and
analyzed for the following characteristics: response time (Figs. 6-8), sensitivity (Figs. 9 and 10),
peak oxidative potential of DA (Fig. 11) RMS noise (Fig. 12), TBC (Fig. 13), and SNR (Fig. 14).
The ability to resolve interfering analytes with PCR using the CFM, CF-MEA-8, and CF-MEA16 is demonstrated in Figure 15.
Temporal Response
Two testing strategies were used to assess temporal response, the elapsed time to 85%
normalized maximal current, in Figures 6-8. For the first strategy, each site of the CF-MEA and
each CFM were centered above the outlet. Measurements collected with the first procedure are
called individually centered responses times. While time consuming, which limited the analysis
to one CF-MEA-16 and CF-MEA-8, these measurements are the most accurate for temporal
response because of the effects of laminar flow and drag (Figs. 6 and 7). For the second strategy,
each site of CF-MEA was not centered above the outlet. Rather, the position of the CF-MEA-16
was adjusted mediolaterally twice, with one position used to assess sites 1 to 8 (i.e., sites 4 and 5
centered above the outlet), and a second position used to assess sites 9 to 16 (i.e., sites 12 and 13
centered above the outlet). One position was used to assess all CF-MEA-8 sites simultaneously
(i.e., sites 4 and 5 centered above the outlet). Measurements collected with the second strategy are
called group-centered responses times. This strategy is more time efficient and permitted the
analysis of several arrays (4 CF-MEA-16s and 3 CF-MEA-8s; Fig. 8). One important caveat with
the second strategy is that array sites were not positioned identically.
16

Figure 6 shows individually centered temporal responses normalized to maximal current
(top) and in absolute current (bottom) for CFMs (A), individual sites of a CF-MEA-8 (B), and
individual sites of a CF-MEA-16 (C). The small contribution of site differences in temporal
response due solely to the DA measurement is depicted in Figure 6C (top), which compares the
fastest response of each CF-MEA-16 site. All responses reach 85% maximum within 400 ms
(INSET). Differences in site sensitivity to DA, as shown by recordings of absolute current for the
CF-MEA-16 (Fig. 6C, bottom), are rectified by calibration.
Figure 7 shows the statistical analysis of normalized individually centered response times.
There was a significant effect of site on response time for the CF-MEA-16 (F(14,30) = 4.41, p =
0.003) and CF-MEA-8 (F(5,12) = 4.16, p = 0.02), and of sensor on response time for CFMs (F(3,8) =
4.61, p = 0.037). However, post-hoc analysis indicated robust consistency of response time across
array site and CFM. This analysis is illustrated by the panels showing Tukey-Kramer groupings
for the CF-MEA-16 (A), CF-MEA-8 (B), and CFM (C). Solid black boxes within a vertical
grouping indicate that values are not statistically significantly different from each other for each
type of sensor. Three large clusters of statistically similar response times (13 out of 15 sites for
two clusters and 10 out of 15 sites for the third cluster) were found for the CF-MEA-16, and all
sites of the CF-MEA-8 exhibited statistically similar response times. With two clusters of similar
response times, each with three out of four sensors, CFMs were more variable than the CF-MEA8 but more similar to the CFM-MEA-16. Average response time for the CF-MEA-16, CF-MEA8, and CFM is plotted in D. Statistical analysis failed to find significant (F2,22 = 3.422, p = 0.51)
effect of sensor type on response time. Thus, analysis of individually centered temporal responses
indicates excellent consistency of response time between individual sites of each array type and
between arrays and CFMs.
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Statistical analysis of normalized group-centered response times is shown in Figure 8.
There was a significant effect of array on response time for CF-MEA-16s (F(3,120) = 37.52, p <
0.0001) and CF-MEA-8s (F(21,48) = 27.71, p < 0.0001). There was also a significant effect of site
on response time in the nested analysis for CF-MEA-16s (F(56,120) = 5.39, p < 0.0001) and CFMEA-8s (F(21,48) = 18.69, p < 0.0001). Panels show Tukey-Kramer groupings for the post-hoc
analysis of sites for CF-MEA-16s (A) and CF-MEA-8s (B). Black boxes, indicating statistically
similar responses times for groupings, can span across arrays of each type. Tukey-Kramer
groupings are the same for all four CF-MEA-16s, and a different set of Tukey-Kramer groupings
is the same for all three CF-MEA-8s. Large clusters of statistically similar response times were
found within individual CF-MEA-16s (e.g., 14 out of 15 sites for CF-MEA-16(1) and CF-MEA16(2); 13 out of 15 sites for CF-MEA-16(3), and 11 out of 15 sites for CF-MEA-16(4)), and across
these arrays (e.g., 40 out of 45 sites across CF-MEA-16(1), (2), and (3); 43 out 60 sites across all
sensors). Taken together, these results indicate excellent consistency of response times for the CFMEA-16.
Clusters of statistically similar response times were observed for CF-MEA-8s (e.g., 10 out
24 sites across all arrays), but they appeared smaller compared to those of CF-MEA-16s. The
decrease in cluster size for the CF-MEA-8 when sites are group centered could be due to the larger
intra-site spacing (160 µm compared with 100 µm for the CF-MEA-16) and the effects of this
spacing on temporal response due to laminar flow and drag. Average response times for the CFMEA-16, CF-MEA-8, and CFM are plotted in C top. There was a significant effect of sensor on
response time (F7,80 = 4.79, p < 0.001). However, there were two large clusters in which 7 out of
8 sensors and 6 out of 8 sensors exhibited statistically similar response times according to Tukey-
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Kramer groupings (C. bottom). Thus, response times were not only largely consistent within a
sensor type but across sensor type as well.
Sensitivity
Figure 9 compares calibration curves for individual sites of four CF-MEA-16s (A),
individual sites of a representative CF-MEA-8 (B), and four CFMs (C). Curves are the best-fit line
to five DA concentrations (0, 0.25, 0.5, 0.75, and 1 μM; average of three replicates), the slope
(nA/µM) of which is used to determine the sensitivity at each sensing site. Background-subtracted
cyclic voltammograms are overlaid for each array site or CFM in top left INSET. Current
surrounding the peak oxidative potential for DA is expanded in bottom right INSET. Variability in
slope appeared less for the CF-MEA-16s compared to the CF-MEA-8 and CFMs.
The statistical analysis of sensor sensitivity is depicted in Figure 10. There was a
significant effect of array on sensitivity for CF-MEA-16s (F(3,120) = 479, p < 0.0001) and CF-MEA8s (F(2,48) = 935, p < 0.0001), and of sensor on sensitivity for CFMs (F(3,8) = 9.02, p = 0.006). There
was also a significant effect of site on sensitivity in the nested analysis for CF-MEA-16s (F(56,120)
= 19.53, p < 0.0001) and CF-MEA-8s (F(21,48) = 54.44, p < 0.0001). Panels show Tukey-Kramer
groupings for the post-hoc analysis of sites for CF-MEA-16s (A) and CF-MEA-8s (B), and of
sensors for CFMs (C). There were clusters of statistically similar sensitivity within individual CFMEA-16s (e.g., 11 out of 15 sites for CF-MEA-16(4); 10 out of 15 sites for CF-MEA-16(3); 9 out
of 15 sites for CF-MEA-16(2)), and across arrays (e.g., 21 out of 30 sites across CF-MEA-16(3)
and (4); 31 out of 45 sites across CF-MEA-16(2), (3), and (4)).
Clusters of statistically similar sensitivity were also observed for the CF-MEA-8s (e.g., 8
out 24 sites across all arrays), but they appeared less robust compared to those of the CF-MEA16s. With two clusters of similar sensitivity, 2 out of 4 and 3 out of 4 sites, the consistency of
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CFMs appeared similar to that of CF-MEA-16s and greater than that of CF-MEA-8s. Overall,
consistency of sensitivity for arrays and CFMs did not appear as robust as for temporal response
(see Figs. 7 and 8). Average sensitivity for the CF-MEA-16, CF-MEA-8, and CFM is plotted in
D. top. There was a significant effect of sensor on sensitivity (F7,80 = 34.93, p < 0.001). CFMs
exhibited a significantly higher sensitivity compared to arrays (on average, 27 and 34% compared
to CF-MEA-16s and CF-MEA-8s, respectively; mean sensitivity for CFM-MEA-16s, CF-MEA8s, and CFMs was 8.0, 7.3, and 11 nA/μM, respectively). The single solid black box for the first
grouping indicates that CFMs are significantly different from all arrays (D. bottom). Across arrays,
there was a cluster of 4 out 7 sites with statistically similar sensitivity according to Tukey-Kramer
groupings, supportive of consistency of sensitivity across arrays.
Peak Oxidative Potential of Dopamine
Figure 11 shows the statistical analysis of peak oxidative potential for DA (see Fig. 9 for
background-subtracted cyclic voltammogram overlays). Three replicate measurements were taken
at each sensing site and analyzed using one-way nested ANOVA (CF-MEA-8s and CF-MEA-16s)
and one-way ANOVA (CFMs and between sensor type). There was a significant effect of array on
peak oxidative potential for CF-MEA-16s (F(3,120) = 830, p < 0.0001) and CF-MEA-8s (F(2,48) =
1315, p < 0.0001), and of sensor on peak oxidative potential for CFMs (F(3,8) = 38, p < 0.0001).
There was also a significant effect of site on peak oxidative potential in the nested analysis for CFMEA-16s (F(56,120) = 2.06, p = 0.0005) and CF-MEA-8s (F(21,48) = 9.21, p < 0.0001). Panels show
Tukey-Kramer groupings for the post-hoc analysis of sites for CF-MEA-16s (A) and CF-MEA-8s
(B) and of sensor for CFMs (C). There were large clusters of statistically similar peak oxidative
potentials within individual CF-MEA-16s (e.g., 15 out of 15 sites for CF-MEA-16(1), (2), (3), and
(4)) but only one large cluster across CF-MEA-16s (e.g., 29 out of 30 sites across CF-MEA-16(1)
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and (2)). Similarly, there were large clusters of statistically similar peak oxidative potentials within
individual CF-MEA-8s (e.g., 8 out of 8 sites for CF-MEA-8(1); 6 out 8 sites for CF-MEA-8(2)
and (3)) but more limited clustering across CF-MEA-8s (e.g., 7 out of 16 sites across CF-MEA8(1) and (3)). There was also a large cluster of statistically similar peak oxidative potentials across
CFMs (e.g., 3 out of 4 sensors). Peak oxidative potential thus appeared to be highly consistent
within an individual array regardless of array type and between CFMs but less consistent across
arrays of the same type. Average peak oxidative potential for the CF-MEA-16, CF-MEA-8, and
CFM is plotted in D. There was a significant effect of sensor on peak oxidative potential (F7,80 =
154, p = 0.0001), and there were only two small clusters of statistically similar values for 3 out 8
sensors, including 3 arrays as well as 2 arrays and the CFMs (Fig. 11D, bottom). Thus, peak
oxidative potential of CFMs was similar to that for some arrays. The robust consistency of this
aspect of electrochemistry across sites within an array will be important for streamlining the timeconsuming technique of PCR for resolving DA from multianalyte FSCV recordings. It should be
noted that data were collected over multiple days, and it is possible that electrochemical variation
between sensors is due to testing variation (i.e. reference electrode, Tris buffer) rather than
difference in sensor performance.
Root-Mean-Square Noise
The results of RMS noise analysis are shown in Figure 12. RMS noise was calculated
using ten consecutive current tracings collected at the peak oxidative potential for DA. There was
a significant effect of array on RMS noise for CF-MEA-16s (F(3,120) = 20.75, p < 0.0001) and CFMEA-8s (F(2,48) = 12.5, p < 0.0001) but not of sensor on RMS noise for CFMs (F(3,8) = 0.96, p =
0.50). There was also a significant effect of site on RMS noise in the nested analysis for CF-MEA16s (F(56,120) = 28.94, p < 0.0001) and CF-MEA-8s (F(21,48) = 5.67, p < 0.0001). Panels show Tukey21

Kramer groupings for the post-hoc analysis of sites for CF-MEA-16s (A) and CF-MEA-8s (B).
No groupings are shown for CFMs (C) because no significant main effect was found. There were
large clusters of statistically similar RMS noise within individual CF-MEA-16s (e.g., 15 out of 15
sites for CF-MEA-16(1) and (2); 14 out of 15 sites for CF-MEA-16(4); 12 out of 15 sites for CFMEA-16(3)), and across CF-MEA-16s (e.g., 30 out of 30 sites across CF-MEA-16(1) and (2); 56
out of 60 sites across all arrays). There were also large clusters of statistically similar RMS noise
within individual CF-MEA-8s (e.g., 8 out of 8 sites for CF-MEA-8(2); 6 out of 8 sites for CFMEA-8(1) and (2)), and across CF-MEA-8s (e.g., 20 out of 24 sites across all arrays). These
results, in combination with no main effect of sensor for RMS noise of CFMs, indicates robust
consistency of RMS noise within sensor type. Average RMS noise for the CF-MEA-16, CF-MEA8, and CFM is plotted in D. There was no significant effect of sensor on RMS noise (F7,80 = 0.672,
p = 0.695), supportive of the consistency of this analytical characteristic across sensor type.
Total Background Current
Figure 13 shows the statistical analysis of TBC. TBC was determined by summing the
absolute value of current readings at all 1,000 points in the background cyclic voltammogram.
There was a significant effect of array on TBC for CF-MEA-16s (F(3,120) = 14603, p < 0.0001) and
CF-MEA-8s (F(2,48) = 4414, p < 0.0001), and of sensor on TBC for CFMs (F(3,8) = 3318, p <
0.0001). There was also a significant effect of site on TBC in the nested analysis for CF-MEA-16s
(F(56,120) = 10672, p < 0.0001) and CF-MEA-8s (F(21,48) = 798, p < 0.0001). Panels show TukeyKramer groupings for the post-hoc analysis of sites for CF-MEA-16s (A) and CF-MEA-8s (B),
and of sensors for CFMs (C). Clusters of statistically similar TBCs were small and sparse within
and among arrays and between CFMs. While TBC appeared to be the least consistent analytical
characteristic within sensor type, it should be considered that this result may be due to the low
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variability of the stable TBC, which increases statistical power for identifying differences. Average
TBC for the CF-MEA-16, CF-MEA-8, and CFM is plotted in D. While there was a significant
effect of sensor on TBC (F7,80 = 2.30, p = 0.034), post-hoc analysis failed to identify a significant
pairwise difference. Thus, despite poor consistency of TBC within sensor type, no sensor was
found to be significantly different from another.
Signal-to-Noise Ratio
The statistical analysis of SNR is depicted in Figure 14. SNR was calculated by dividing
maximal current of the signal produced by 1 μM DA bolus by RMS noise. There was a significant
effect of array on SNR for CF-MEA-8s (F(2,48) = 10.55, p < 0.0002) but not for CF-MEA-16s
(F(3,120) = 2.03, p = 0.114) or of sensor on SNR for CFMs (F(3,8) = 1.36, p = 0.32). There was also
a significant effect of site on SNR in the nested analysis for CF-MEA-16s (F(56,120) = 2.18, p <
0.0001) and CF-MEA-8s (F(21,48) = 2.72, p < 0.0001). Panels show Tukey-Kramer groupings for
the post-hoc analysis of sites for CF-MEA-16s (A) and CF-MEA-8s (B). No groupings are shown
for CFMs (C) because no significant main effect was found. There were large clusters of
statistically similar SNR within individual CF-MEA-16s (e.g., 15 out of 15 sites for CF-MEA16(1) and (2); 14 out of 15 sites for CF-MEA-16(3) and (43)), and across CF-MEA-16s (e.g., 30
out of 30 sites across CF-MEA-16(1) and (2); 44 out of 45 sites across CF-MEA(1), (2), and (4);
56 out of 60 sites across all arrays). There were also large clusters of statistically similar RMS
noise within individual CF-MEA-8s (e.g., 8 out of 8 sites for CF-MEA-8(1), (2), and (3)), and
across CF-MEA-8s (e.g., 22 out of 24 sites across all arrays). SNR thus appeared to be the most
consistent analytical characteristic within sensor type. Average SNR for the CF-MEA-16, CFMEA-8, and CFM is plotted in D. In agreement with consistency within sensor type, statistical
analysis failed to find a significant effect of sensor on SNR (F7,80 = 1.75, p = 0.11). Interestingly,
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SNR was therefore the most consistent analytical characteristic overall; however, this runs counter
to our finding that sensitivity varied significantly between sensor type. This finding is important
for in vivo measurements because SNR determines detection limit.
Principle Component Regression
The ability of CF-MEAs to resolve a mixed analyte signal recorded by FSCV into
individual analytes using the approach of PCR is demonstrated in Figure 15. PCR is a combined
approach utilizing principle component analysis and inverse least-squares regression that has been
applied to resolve DA from a multianalyte raw FSCV record obtained by a CFM (Heien et al.,
2004; Keithley et al., 2009). For this test, PCR was used to resolve individual responses for DA
(Fig. 15A) and a change in pH (ΔpH; Fig. 15B) from mixtures of DA and ΔpH (Fig. 15C-D). The
pH of brain extracellular fluid is dynamic and changes with neuronal activity (Venton et al., 2003).
While H+ is not electroactive, the oxidation and reduction of chemical groups on the surface of the
carbon fiber are pH sensitive (Kawagoe et al., 1993). Thus, ΔpH will generate a temporal response
and characteristic voltammogram (Fig. 15B). More importantly, ΔpH distorts the DA current
measured at the peak oxidative current for DA in the temporal response when both analytes are
present (Fig. 15C-D). The two mixtures of DA (1-µM) and ΔpH were selected because the acidic
pH (7.15) adds to the DA temporal response while the basic pH (7.65) subtracts from the DA
temporal response (Fig. 15C-D). The pH of the calibration buffer flowing across the sensor prior
to analyte injection in FIA is 7.4. As a result, ΔpH responses represent the difference from a
baseline pH of 7.4.
As shown in Figure 15C and D, a single representative site on a CF-MEA-16 or CF-MEA8 was able to revolve DA and ΔpH from a mixture of the two, similar to the performance of a CFM
for PCR. Agreement between observed (measured) and predicted (PCR-resolved) responses for
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the two analytes was statistically significant for all sensors as assessed by the Pearson correlation
coefficient. This result underscores the ability of CF-MEAs to operate successfully for FSCV in
the chemically complex extracellular milieu of the brain.
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CHAPTER IV: RESULTS - IN VIVO CHARACTERIZATION OF CF-MEAs
Background
The measurement of DA signaling in the midbrain provides insight into the neurological
basis of learning and behavior. The striatum is a midbrain region heavily innervated by DA
neurons, and these DA neurons signal in distinct tonic and phasic modes in vivo to signal target
neurons (Schultz, 2007; Dreyer et al., 2010). In the tonic mode, DA neurons discharge irregularly
at low frequencies (≈5 Hz) (Grace and Bunney, 1984) and establish a baseline level of extracellular
DA. This DA tone enables movement, cognition, and motivation (Schultz, 2007). In response to
certain stimuli, including novelty, salient stimuli, social interaction, and reward, DA neurons fire
in bursts of action potentials at higher frequencies (>15 Hz) to signal and reinforce the value of
performing advantageous behaviors (Floresco et al., 2003; Robinson et al., 2011; Hamid et al.,
2016; Mohebi et al., 2019). During this phasic mode of signaling, action potential bursts lead to
sub-second to second increases in extracellular DA called transients that ride on top of DA tone
(Garris and Keefe, 2015) and are detectable by conventional FSCV. DA transients drive the
learning of predictive cues and play a significant role in reward learning (Covey et al., 2014)
suggesting alteration of their frequency, amplitude, and duration will lead to modification of
behavior. Indeed, drugs of abuse, particularly amphetamine (AMPH), are known to increase the
frequency, amplitude, and duration of DA transients.
CF-MEAs Capture Heterogeneity of Electrically Evoked Dopamine Signals
The urethane-anesthetized preparation was used to assess the performance of the CF-MEA16 in vivo and demonstrates the heterogeneity of electrically evoked DA signals in the striatum
(Fig. 16A). The heterogeneous nature of the striatum results, at least in part, from a patchwork of
distinct DA kinetic domains that are characterized by a variety of DA signal types. Fast and slow
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kinetic domains in the striatum are distinguishable by examining the amplitude and temporal
profile of electrically evoked DA signals (Moquin and Michael 2009). Striatal DA signals can be
categorized into fast and slow domains, with fast DA signals further subdivided into four different
types based on release kinetics (Types 1-4; Taylor et al. 2015). In fast domains, DAT favors both
rapid DA release and uptake. In the slow domain, DAT favors non-action potential-dependent DA
efflux and slow DA uptake. The resulting high levels of DA tone caused by these factors inhibit
DA release by acting on autoreceptors. Conventionally, CFMs have been optimized in vivo for a
single fast DA signal type (Type 1), and comparatively little work has been done to characterize
the remaining types more fully. Understanding of these previously unexplored signal types may
provide further insight into the underlying mechanisms of reward learning. Moreover, the striatum
is also anatomically divided into patch and matrix compartments, each with distinct afferent (input)
and efferent (output) connections and more importantly, distinct DA dynamics (Brimblecombe &
Cragg, 2015, 2017; Salinas et al., 2016). DA neurons innervate both patch and matrix
compartments but are denser in patch. Additionally, DA release differs between patch and matrix
compartments in distinct anatomic locations. In the dorsal striatum, DA release is greater in the
matrix, whereas DA release is greater in the patch in the ventral striatum (Brimblecombe & Cragg,
2015).
A CF-MEA-16 was implanted in the dorsomedial striatum and a stimulating electrode was
implanted in the medial forebrain bundle to electrically activate ascending DA axons. Previous
work using FSCV at a CFM in anesthetized rats has demonstrated a profound heterogeneity of
electrically evoked DA signal amplitude and dynamics in the striatum (May and Wightman,
1989;Garris et al., 1994) that have more recently been classified by type (Walters et al.,
2015;Taylor et al., 2015). With a similar recording site spacing (100 µm) as the striatal
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heterogeneity previously described by the CFM, the CF-MEA-16 is potentially well suited for
capturing the different dynamics and amplitudes of these DA signals with similar high fidelity but
simultaneously across a much larger measurement field. Thus, monitoring the heterogeneity of
evoked striatal DA signals is a robust test of the CF-MEA-16 that will also provide additional
insight into the heterogeneity of DA neurotransmission in the striatum.
Figure 16A describes measurements of electrically evoked transient-like DA signals as the
CF-MEA-16 is lowered in 100 µm-increments ventrally in the striatum. The position of the
stimulating electrode, which applied 0.4-s (24 pulse) trains, was initially optimized using a CFM
and fixed in the medial forebrain bundle for all measurements. The heat map (top) visibly shows
heterogeneity of the maximal concentration of DA evoked by the electrical stimulation ([DA]max)
within the recorded portion of the striatum. Each row represents a simultaneous recording at each
site (100-μm resolution) of the CF-MEA-16, while columns represent recordings taken separately
as the CF-MEA-16 is lowered in 100-μm increments. Recordings from a CFM lowered earlier in
the experiment through approximately the middle of this recorded region demonstrate similar
heterogeneity. Dynamic information about the DA signals is revealed by individual temporal
responses at select sites (Fig. 16, bottom). Consistent with similar response times demonstrated by
FIA (see Fig 6), in vivo signals of similar amplitude and recorded by an individual site on the CFMEA-16 and a CFM substantively overlay.
Differences in the temporal responses electrically evoked by a longer stimulus train (3
versus 0.4 s) form the basis for categorizing striatal DA signals into fast and slow, with fast signals
further subdivided into types 1 to 4 (Taylor et al., 2015; Fig. 17). Fast and slow domains in the
striatum exhibit distinct regulation of extracellular DA levels and pharmacological profiles
(Moquin and Michael, 2009; Moquin and Michael, 2011; Taylor et al., 2012). The CF-MEA-16
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uniquely identified fast and slow types of electrically evoked DA signals and all but one (type 3)
of the fast types (Fig. 17A) across a broad region of the dorsal striatum. Figure 17B illustrates the
temporal and dynamic profiles of the kinetically diverse DA signals observed, with Types 1, 2,
and 4 fast signals leading to increased concentrations of DA detected within 200 ms. The slow
domain identified takes appreciably longer to rise above the detection limit.
This striatal heterogeneity also extends more laterally as demonstrated by a different CFMEA-16 implanted in another rat (Fig. 18A), indicating that even the expanded number of
recording sites for FSCV offered by the CF-MEA-16 compared to a CFM does not fully capture
the richness of striatal DA signals. All but one recording location in the striatum in which 0.4-s
trains failed to detect DA (Fig. 18A) produced measurable DA signals when evoked by 3-s trains
(Fig 18B). Surprisingly, most recording sites with undetectable DA signals were type 1, which
exhibited the highest [DA]max evoked by 0.4-s trains (Fig. 18C). Additional work is needed to
investigate these interesting and surprising findings.
In Vivo CF-MEA Characteristics
Of critical importance is determining both the stability of sensors over time as well as
establishment of dynamic sensing range. Signals recorded at the same site over a period of 25 min
are stable (Fig. 19A). Moreover, the punctate nature of the stability heat map suggests that gradual
changes in DA sensitivity over time are not responsible for the differences in [DA]max observed
during depth studies (see Figs. 16A and 18A). The ability of the CF-MEA-16 to record signals of
different amplitudes faithfully in vivo is supported by site-specific increases in DA concentration
with increasing stimulus pulse number (Fig. 19B).
Prior FIA characterization of CF-MEA-16s demonstrated similar SNR for DA monitoring
with FSCV as CFMs. This result is critical for establishing the potential of CF-MEAs for in vivo
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monitoring of all DA signals previously characterized by CFMs, particularly signals with low
amplitudes near the detection limit. To assess whether this similarity of SNR holds true after
implantation in the brain, in vivo SNRs for the CF-MEA-16 and CFM were compared. SNRs in
Figure 20A and B top were calculated from DA signals electrically evoked by 0.4-s trains and
shown in Figure 16A and Figure 18A for two different pairings of a CF-MEA-16 and CFM in
different animals, respectively. Measurements with the single CFM or three CFMs were collected
first. After CFM removal, the array was implanted to a similar mediolateral, anteroposterior, and
dorsoventral location in the striatum. Not unexpectedly, there is heterogeneity of SNR that appears
to mirror [DA]max for both CF-MEA-16 and CFM. For a given pair of sensors, the heterogeneity
of SNR also appears similar for the CF-MEA-16 and CFM, at least for some sub-regions of the
striatum.
To quantitatively compare SNR between the two sensor types, values for the three most
middle sites of each array were averaged. These three sites approximate the mediolateral location
of the single CFM in Figure 20A and the middle of the three CFMs in Figure 20B. The other two
CFMs in Figure 20B are located either more medial or lateral to the array. Although equivalent
recording locations are approximate for each array and associated CFM, the location of the
stimulating electrode is fixed for all measurements in each animal, which promotes comparison
SNRs. Figures 20A and B bottom show average SNR for each pairing of CF-MEA-16 and CFM.
SNR was not different between the array and CFM in Figure 20A (t22 = 1.378; p = 0.18) or Figure
20B (t18 = 0.7413; p = 0.47). These in vivo results for SNR are consistent with those from FIA and
thus highlight the similarity of this important analytical characteristic between the CF-MEA-16
and CFM for monitoring striatal DA signals in vivo.
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CF-MEAs Capture Effects of AMPH on Baseline and Phasic Dopamine Signals
The psychostimulant amphetamine (AMPH) is a potent inhibitor of DAT that exhibits
therapeutic efficacy in the treatment of attention deficit disorder (ADD)/ attention deficit
hyperactivity disorder (ADHD) and narcolepsy (Sulzer et al., 2005; Arnsten, 2006). Because DAT
inhibition increases extracellular levels of brain DA, particularly in those regions involved in
reward learning (DiChiara and Imperato, 1988), AMPH is also known to exhibit significant abuse
potential (Rothman and Baumann, 2006; Berman et al. 2008;). While the mechanism of action by
which AMPH increases brain DA levels has been extensively studied for decades (Sulzer et al.,
2005), more recent work has aimed at providing insight into the presynaptic mechanisms of DA
release and uptake (Covey et al., 2014). The complexity of DA signaling is increased in the
presence of AMPH due to its ability to both block and reverse the function of DAT as well as its
ability to augment vesicular DA release (Avelar et al., 2013). At this point, AMPH-induced
changes in DA concentration are incompletely understood and hypothesized to be a result of
action-potential independent DA efflux, action-potential dependent exocytotic release events, or a
combination of the two.
As expected, AMPH modulates electrically evoked DA signals in the striatum. The effects
of AMPH (1.0-mg/kg i.v.) on electrically evoked transient-like DA signals in the striatum of the
anesthetized rat and assessed by a CF-MEA-16 are shown in Figure 21. While there is
heterogeneity in the pre-AMPH DA signals (Fig. 21A, left) as previously shown above for these
0.4-s stimulus trains (see Figs. 16A and 18A), AMPH increased the amplitude of temporal
responses at all sites (Fig. 21A, right). The drug-induced increase in signal amplitude is
voltammetrically attributed to DA. A heat map highlights the spatially heterogenous nature of
these AMPH effects, both in terms of absolute and relative increases in [DA]max (Fig. 21B, first
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panel). Similar to effects on amplitude as demonstrated by the raw recordings, AMPH increased
[DA]max at all sites.
Extracellular DA levels are tightly controlled by the presynaptic mechanisms of DA release
and uptake, which can be resolved using mathematical means from electrically evoked DA signals
measured by FSCV at a CFM (Wightman et al., 1988;Wu et al., 2001). After signal conditioning
to remove the effects of DA adsorption to the surface of the carbon fiber (i.e., “hang-up”), temporal
responses recorded by the CF-MEA-16 were kinetically analyzed for three parameters, Rp, kU, and
kT, describing DA release, uptake, and diffusion, respectively (Walters et al., 2014;Walters et al.,
2015). Similar to [DA]max (Fig. 21B, first panel), AMPH increased the release term, Rp, at all sites
(Fig. 21B, second panel). In contrast, AMPH decreased the uptake term, kU, at all sites (Fig. 21B,
third panel), consistent with its established mechanism of a competitive DA uptake inhibitor
(Sulzer et al., 2005). Previous in vivo studies using FSCV at a CFM to record electrically evoked
transient-like DA signals have also reported AMPH-induced increases in DA release and decreases
in DA uptake (Daberkow et al., 2013;Covey et al., 2013). The decrease in the diffusion term kT,
with AMPH (Fig. 21B, fourth panel) is a novel finding, but it has been described previously for
another competitive DA uptake inhibitor, GBR12909, using an identical kinetic model (Walters et
al., 2020). However, analysis with an expanded model attributed this decrease in kT to DA uptake.
Nevertheless, it is interesting to note that, like [DA]max, parameters, and the effects of AMPH on
these parameters were spatially heterogeneous. This result underscores the spatial coverage
afforded by CF-MEAs for pharmacological investigations of DA presynaptic mechanisms in vivo
but with the exquisite analytical characteristics of the CFM.
Using FSCV at a CFM, AMPH has been show to increase DA baseline via an unknown
mechanism as well as the frequency, amplitude, and duration of DA transients (Daberkow et al.,
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2013; Covey et al., 2013; Covey et al., 2016). In contrast to electrically evoked measurements
using FSCV, whose chemical identify is established by voltammograms (vide supra), phasic DA
signals and changes in DA baseline require more robust means to determine analyte identify. In
particular, changes in extracellular pH reflecting neuronal activity and sensor drift distort the
voltammetric measurement of DA over longer periods of time and must be isolated using PCR.
Demonstrating the ability of CF-MEAs to monitor changes in DA baseline as well as phasic DA
signals is thus critical for establishing this sensor approach for investigations targeting naturally
occurring and drug-evoked DA signals.
Pre-drug (i.e., non-drug) recordings from a CF-MEA-16 implanted in the striatum of an
anesthetized rat failed to detect either DA transients or changes in baseline DA levels when
resolved by PCR (Fig. 22A). In sharp contrast, i.v. administration of 1.0-mg/kg AMPH robustly
activated DA transients (post-AMPH; Fig. 22B and C). DA transients occurred synchronously in
rapid succession, to the extent causing a gradual increase in extracellular DA, three minutes after
drug administration (Fig. 22B). Interestingly, five minutes after drug administration, individual
transients were detectable at some, but not all, sites of the CF-MEA-16 (Fig. 22C).
To assess the ability to monitor longer-duration changes in extracellular DA, AMPH (10
mg/kg) was combined with the D2 DA antagonist raclopride (2.0 mg/kg) and administrated i.p.
AMPH has been shown to induce inhibition of burst firing in DA cells by increasing extracellular
DA levels, particularly by activating D2 DA receptors, and this effect is compounded in the
anesthetized rat preparation. Both effects can be overcome with administration of raclopride (Shi
et al., 2000). Indeed, a cocktail of psychostimulant and D2 DA antagonist administered via this
route has previously been shown to elicit a variety of DA signals, including some with a duration
of several seconds (Robinson et al., 2014). This drug cocktail elicited a large (>0.5 µM) and
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extended (several minutes) increase in DA baseline that was detected at all sites of the CF-MEA16, albeit to varying degrees, (Fig. 22D). In contrast, a shorter duration (≈30 s) and smaller (≈200
to 300 µM) increase in DA baseline was only detected at a few recording sites (Fig. 22E).
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CHAPTER V: CONCLUSION
Thorough FIA characterization suggests these self-insertable CF-MEAs are generally
similar to conventional CFMs in terms of response time, RMS noise, TBC, and SNR. One
difference across sensors was the peak oxidative potential aspect of electrochemistry. Although
peak oxidative potential differed across sensors, it was similar between CFMs and some arrays.
Another difference across sensors was sensitivity, which was somewhat greater for CFMs
compared to all arrays (≈30% on average), and this result runs counter to the findings that RMS
noise and SNR ratio did not vary across sensors in either in vivo or FIA applications. While we do
not have a ready explanation for this discrepancy, it is entirely possible that differences in RMS
noise between sensors escaped our statistical analysis. Nevertheless, it should be emphasized that
as the determinant of detection limit, the critical analytical characteristic of SNR was similar
between arrays and CFMs. It is also important to consider the robust consistency of SNR within
and between sites of arrays, indicating that each site and array will bring a similar detection limit
to monitoring DA signals.
Collectively considering the analysis of temporal response and SNR, results indicate that
CF-MEAs are capable of detecting DA signals of the same dynamics and amplitude as CFMs.
Moreover, the robust consistency of the arrays with regard to these analytical characteristics afford
the important advantage that each site of an array and each array will be as similarly capable as
the CFM for monitoring DA signals. Overall, the analytical characteristics of CF-MEA-8 and CFMEA-16 for DA monitoring with FSCV thus compare favorably with those of the CFM.
In vivo, CF-MEAs identified fast and slow types of electrically evoked DA signals and four
out of five previously described signal types across a broad region of the dorsal striatum.
Moreover, we have demonstrated heterogeneity in both electrically evoked [DA]max as well as the
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kinetic parameters associated with modeling phasic DA signaling events. Finally, we have shown
that AMPH modulated electrically evoked transient-like DA signals, changes in baseline DA
concentration, and phasic DA transients are robustly detectable by CF-MEAs. Taken together,
these results demonstrate that CF-MEAs afford a similar utility as CFMs for monitoring brain DA
signals in a temporally, chemically, and spatially resolved manner while providing the
transformative advantage of substantively expanded spatial coverage for superior characterization.
Given the favorable performance of CF-MEAs in this study, the use of this class of
microsensors in future full-scale studies is seemingly justified. While we observed changes in
baseline DA levels in the presence of AMPH, it should be emphasized that the mechanism of
AMPH action on increasing DA tone is not established. Future investigations utilizing CF-MEAs
may help reconcile discrepant results regarding action potential-dependent and independent
actions of AMPH on DA signaling (Sulzer et al., 2005;Covey et al., 2014). Additional work is also
needed to characterize the utility of CF-MEAs more fully in the freely behaving animal.
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APPENDIX: FIGURES
Figure 1: Representative sensors and system components

Figure 1. Representative sensors and system components. A. representative CFM, CF-MEA 8,
and CF-MEA-16 sensors are shown at left. The CFM has a single carbon fiber (~7 μm diameter,
not visible) trimmed to a length of 50 μm. The borosilicate capillary tube is sealed with epoxy, and
electrical connection is established by melting bismuth alloy to secure a copper wire (yellow). A
gold pin is soldered in place to facilitate coupling with the headstage. CF-MEA 8 and CF-MEA16 are shown connected via an Omnetics coupler to a headstage (headstage is also shown
connected to the lead cable in B). INSETS depict the silicone support structure present in the CFMEA-16. The silicone support reduces in size concentrically as it becomes more distal to the
Omnetics connection. The lead cable in B is connected to the breakout box depicted in C, and the
breakout box is powered by a standalone power supply shown in D.
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Figure 2: Flow Injection Apparatus Schematic

Figure 2: Flow Injection Apparatus Schematic. Components of the flow injection apparatus are
depicted including the computer, TTL pulse, controller box, actuator, loop injector, and buffer
reservoir. A known concentration of DA is injected via syringe into the loop injector. Tris buffer
is continually injected into the reservoir at a user-defined rate. When generated by the computer,
the TTL pulse triggers a nitrogen-driven actuator to switch injected solution from Tris buffer to a
bolus of DA-containing buffer.
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Figure 3. Flow Injection Interface Placement by Sensor Type

Figure 3. Flow Injection Interface Placement by Sensor Type. A photograph depicting the FIA
apparatus reservoir and outlet is shown at left. A conceptual rendering of the sensing surface(s) of
a CFM (top right), CF-MEA-8 (middle right), and CF-MEA-16 (bottom right) is shown to
highlight considerations associated with CF-MEA-8 and CF-MEA-16 dorsoventral and
mediolateral placement at the tubing outlet of the FIA apparatus.
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Figure 4: FIA Characterization of MEA-8
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Figure 4. FIA Characterization of MEA-8. A. A conceptual rendering of the measurement of
the leading edge of a DA bolus by the CF-MEA-8 is shown. The position of the CF-MEA-8 was
adjusted in the mediolateral (ML) and dorsoventral (DV) planes for measurements described in
subsequent panels. Color key for recording site applies to panels B to G. Temporal responses to
the DA bolus and normalized to maximal current are shown for the CF-MEA-8 centered (ML = 0
mm) above the tubing outlet at a DV position 0.0 (B), +0.5 (C), +1.0 (D), +1.5 (E), +2.0 (F), and
+2.5 (G) mm. INSETs show an expanded view of the response to the leading edge of the DA bolus.
H. The fastest response at each DV position is shown. Distance is shown by the adjacent color
key. The response collected at DV +1.0 mm is as fast if not faster than all other responses. This
distance is thus suitable for assessing response time and provides a safe distance above the outlet
to position CF-MEAs. Also notice how responses recorded by the lateral sites are more distorted
at closer distances compared to far, perhaps due to turbulent flow as the buffer stream leaves the
tubing, enters the reservoir, and interacts with reservoir sides. Dashed line in B to H is 85% of
maximal current. Temporal responses to the DA bolus and normalized to maximal current are
shown for a CF-MEA-8 centered above the tubing outlet (I; ML = 0 mm) and offset by 0.5 mm
(J; ML = -0.5 mm). Line color follows key in A. The fastest response in I, site 5, is no longer the
fastest response in J when moved away the center of the tubing outlet. Conversely, the slowest
response in I, site 1, becomes the fastest response in J when it is centered above the tubing outlet.
Line color follows key in A. K. Responses for sites 1 and 5 in I and J are reproduced for clarity
(top). Note how well responses from sites 1 and 5 overlap when positioned similarly (within ≈160
µm, the distance between sites), above the tubing outlet. The pseudocolor plot and individual
voltammogram for the response described by the solid black line (site 1, ML -0.5 mm; bottom)
indicate that DA is the measured analyte. Horizontal black line of the pseudocolor plot delineates
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current measured at the peak oxidative potential for DA. Vertical dashed red line delineates the
location of the individual background-subtracted cyclic voltammogram shown in red. Collectively,
results shown in I to K demonstrate that the temporal response is more related to position in the
measurement field than along the CF-MEA-8. All temporal responses recorded a 10-s, 1-µM DA
bolus and are single recordings.
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Figure 5: Laminar flow of a DA bolus with FIA
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Figure 5. Laminar flow of a DA bolus with FIA. A. CFM and CF-MEA-16 FSCV measurements
are shown to the left and right, respectively. Top is a conceptual rendering of the leading edge of
a DA bolus as it arrives at the reservoir opening (1.2 mm). The CFM (top left) or CF-MEA-16 (top
right) is placed 1 mm above the opening and positioned at different mediolateral locations. After
entering buffer flow (4 ml/min) at the injection port, the leading edge of the DA bolus is distorted
as it travels the length (≈6 cm) of tubing to the reservoir due to slower velocities of laminar flow
nearest the tubing wall resulting from drag. Thus, the leading edge of the DA solution arrives faster
in the tubing center versus the edges. Left (middle) shows recordings of the DA bolus by a CFM
either placed in the center (0 mm) of the opening or 0.5 mm to either side (±). Right (middle) shows
recordings of the DA bolus by center site 9 of the MEA-16 when placed at similar locations.
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INSETs show the initial response to the DA bolus. Line color follows the key in top. Bottom shows
pseudocolor plots (time - x axis, applied potential - y axis, measured current - z axis) displaying
all background-subtracted voltammograms serially in time that generated the dashed black (left)
and dashed blue (right) temporal responses above. Horizontal dashed lines delineate current of the
temporal responses measured at the peak oxidative potential for DA. Vertical dashed red lines
delineate the location of the individual background-subtracted cyclic voltammograms shown in
red (applied potential - x axis, measured current - y axis) in the INSETs. B. Responses to a DA
bolus were recorded by center site 9 of a MEA-16 as it is positioned at 100-µm increments across
the tubing outlet (left; line color follows the key in A, top right.) and simultaneously at each site
of the same MEA-16 (right; line color follows adjacent key). Temporal responses are expanded in
INSETs (top; dashed line is 85% maximal response). Pseudocolor plots for each recording site
show the portion of the applied potential (+0.28 to 0.96 V) canvasing DA oxidation (bottom). All
temporal responses recorded a 5-s, 1-µM DA bolus, are normalized to maximal current, and are
the average of 3 replicates.
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Figure 6: Individually centered response times
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Figure 6: Individually centered response times. Individually centered temporal responses to a
5-s DA bolus normalized to maximal current (top) or in absolute current (bottom) are shown for
CFMs (A), and each site of a CF-MEA-8 (B) and CF-MEA-16 (C). INSETs show expanded view
of the response to the leading edge of the DA bolus. CFMs and arrays were centered (ML = 0 mm)
above the tubing outlet at DV position of +1.0 mm. ML position of the CF-MEA-8 was adjusted
in increments of 160 μm, the distance between sites, to center individual sites. ML position of the
CF-MEA-16 was adjusted in increments of 100 μm, the distance between sites, to center individual
sites. Dashed line is 85% maximum.
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Figure 7: Statistical analysis of individually centered temporal responses
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Figure 7: Statistical analysis of individually centered temporal responses. A nested one-way
ANOVA was performed on individually centered response times for a CF-MEA-16 (A) and CFMEA-8 (B), and a one-way ANOVA was performed on individually centered response times for
CFMs (C). Temporal response to a 5-s, 1-µM DA bolus was determined as time to 85% of maximal
normalized current for CFMs and sites that were individually centered (ML = 0 mm) 1-mm above
the tubing outlet. A total of three replicates were collected for each site or CFM; data are
mean±SEM of these replicates. Color scale represents response time relative to each sensor type.
Columns with solid black boxes are Tukey-Kramer groupings determined from post-hoc analysis.
A solid black box within a grouping indicates that values are not significantly different from each
other or conversely, that they are significantly different from values indicated by an open box. A
one-way ANOVA was performed on response time across the CF-MEA-16, CF-MEA-8, and CFM
(D). Data are mean±SEM of each site of the arrays or CFM after replicate averaging. No significant
effect of sensor type on individually centered response time was found.
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Figure 8: Statistical analysis of group-centered response times
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Figure 8: Statistical analysis of group-centered response times. A nested one-way ANOVA
was performed on group-centered response times for CF-MEA-16s (A) and CF-MEA-8s (B).
Response time was determined as in Figure 6, except that the position of the CF-MEA-16 was
adjusted only twice, centering between sites 1 to 8 or 9 to 16 for two sets of 8 simultaneous
recordings. The position of the CF-MEA-8 was not moved; thus, all 8 sites were simultaneously
recorded. A total of three replicates were collected for each site; data are mean±SEM of these
replicates. A one-way ANOVA was performed on response time across CF-MEA-16s, CF-MEA8s, and CFMs (C). Data are mean±SEM of each site of the arrays or CFM (from Figure 6D). Post-
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hoc Tukey-Kramer analysis is depicted by statistical groupings as in Figure 7. Color scale
represents response time relative to each sensor type in A and B and relative to sensor in C.
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Figure 9: Comparison of calibration curves and peak oxidative electrochemistry
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Figure 9: Comparison of calibration curves and peak oxidative electrochemistry. Calibration
curves and background-subtracted cyclic voltammograms are shown for four CF-MEA-16s (A), a
CF-MEA-8 (B), and four CFMs (C). Calibration curves are the best-fit line to maximal current
obtained from five DA concentrations (0-, 0.25-, 0.5-, 0.75-, and 1-μM; average of three replicates)
delivered as a 5-s bolus. Sensors were centered and positioned 1 mm above the tubing outlet. Top
INSETs show overlays of voltammograms collected from the 1-μM DA bolus. Average peak
oxidative and reductive potentials for DA are identified and depicted by dashed red vertical lines.
Bottom INSETs expand the current canvassing peak oxidative potential.
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Figure 10: Statistical analysis of sensitivity
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Figure 10: Statistical analysis of sensitivity. A nested one-way ANOVA was performed on
sensitivity for CF-MEA-16s (A) and CF-MEA-8s (B), and a one-way ANOVA was performed on
sensitivity for CFMs (C). A total of three replicates were analyzed for each site or CFM; data are
mean±SEM of these replicates. A one-way ANOVA was performed on sensitivity across CFMEA-16s, CF-MEA-8s, and CFMs (D). Data are mean±SEM of each site of the arrays or CFM
after replicate averaging. Post-hoc Tukey-Kramer analysis is depicted by statistical groupings as
in Figure 7. Color scale represents response time relative to each sensor type in A, B, and C and
relative to sensor in D.
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Figure 11: Statistical analysis of peak oxidative potential for DA
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Figure 11. Statistical analysis of peak oxidative potential for DA. A nested one-way ANOVA
was performed on peak oxidative potential for CF-MEA-16s (A) and CF-MEA-8s (B), and a oneway ANOVA was performed on peak oxidative potential for CFMs (C). A total of three replicates
were analyzed for each site or CFM; data are mean±SEM of these replicates. A one-way ANOVA
was performed on peak oxidative potential across CF-MEA-16s, CF-MEA-8s, and CFMs (D).
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Data are mean±SEM of each site of the arrays or CFM after replicate averaging. Post-hoc TukeyKramer analysis is depicted by statistical groupings as in Figure 7. Color scale represents response
time relative to each sensor type in A, B, and C and relative to sensor in D.
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Figure 12. Statistical analysis of RMS noise
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Figure 12. Statistical analysis of RMS noise. A nested one-way ANOVA was performed on
RMS noise for CF-MEA-16s (A) and CF-MEA-8s (B), and a one-way ANOVA was performed
on RMS noise for CFMs (C). A total of three replicates were analyzed for each site or CFM; data
are mean±SEM of these replicates. No significant effect of CFM on RMS noise was found. Post74

hoc Tukey-Kramer analysis is depicted by statistical groupings as in Figure 7. Color scale
represents sensitivity relative to each sensor type. A one-way ANOVA was performed on RMS
noise across CF-MEA-16s, CF-MEA-8s, and CFMs (D). Data are mean±SEM of each site of the
arrays or CFM after replicate averaging. No significant effect of sensor on RMS noise was found.
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Figure 13: Statistical analysis of TBC
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Figure 13: Statistical analysis of TBC. A nested one-way ANOVA was performed on RMS noise
for CF-MEA-16s (A) and CF-MEA-8s (B), and a one-way ANOVA was performed on RMS noise
for CFMs (C). A total of three replicates were analyzed for each site or CFM; data are mean±SEM
of these replicates. Post-hoc Tukey-Kramer analysis is depicted by statistical groupings as in
Figure 7. Color scale represents sensitivity relative to each sensor type. A one-way ANOVA was
performed on TBC across CF-MEA-16s, CF-MEA-8s, and CFMs (D). Data are mean±SEM of
each site of the arrays or CFM after replicate averaging. A significant effect of sensor on TBC was
found, but post-hoc analysis failed to identify a significant pairwise difference.
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Figure 14: Statistical Analysis of SNR
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Figure 14: Statistical analysis of SNR. A nested one-way ANOVA was performed on RMS noise
for CF-MEA-16s (A) and CF-MEA-8s (B), and a one-way ANOVA was performed on RMS noise
for CFMs (C). A total of three replicates were analyzed for each site or CFM; data are mean±SEM
of these replicates. No significant effect of CFM on RMS noise was found. Post-hoc Tukey79

Kramer analysis is depicted by statistical groupings as in Figure 7. Color scale represents
sensitivity relative to each sensor type. A one-way ANOVA was performed on SNR across CFMEA-16s, CF-MEA-8s, and CFMs (D). Data are mean±SEM of each site of the arrays or CFM
after replicate averaging. No significant effect of sensor on SNR was found.
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Figure 15: PCR for resolving DA and ΔpH
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Figure 15: PCR for resolving DA and pH. Temporal responses for different concentrations of
DA (A) and values for ΔpH (B) and collected by FIA are shown for a CFM (top) and a one site of
a CF-MEA-8 (middle) and CF-MEA-16 (bottom), respectively. Current for both DA and ΔpH was
measured at the peak oxidative potential for DA. INSETs are background-subtracted cyclic
voltammograms. The DA concentrations are 0.25, 0.50, 0.75, and 1.0 μM, and ΔpH values are 0.50, -0.25, +0.25, and +0.50. The pH of the calibration buffer flowing across the sensor prior to
analyte injection in FIA is 7.4. All DA solutions were also at a pH of 7.4. The voltammograms and
calibrations create the training sets for PCR. C and D show PCR of two different mixtures of DA
and ΔpH, 1-µM DA and a ΔpH of -0.25 and 1-µm DA and a ΔpH of +0.25, respectively, for the
same CFM (top) and same single site of a CF-MEA-8 (middle) and CF-MEA-16 (bottom). The
mixtures were selected because the acidic pH adds to the DA temporal response and the basic pH
subtracts from the DA temporal response, thus providing a good test of the PCR analysis. Temporal
responses and voltammograms (INSETs) of the mixtures are shown by black lines. The distortion
of DA monitoring by ΔpH is clearly evident in the temporal response and voltammogram. The
corresponding DA and pH temporal responses from the training set (“observed”) are shown by
orange and green lines, respectively. Individual temporal responses for DA and ΔpH resolved by
the PCR (“predicted”) are shown by blue and aqua lines. Pearson correlation coefficients (r) listed
in each panel describe agreement between predicated and observed recordings during the 5-s
analyte bolus. All coefficients were significant.
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Figure 16: Heterogeneity of 24-p electrically evoked DA signals in the striatum

Figure 16. Heterogeneity of electrically evoked 24-p DA signals in the striatum. A. Transientlike DA signals electrically evoked by 0.4-s (24-pulse) trains were measured in the striatum of the
urethane-anesthetized rat by a CFM or CF-MEA-16 lowered in 100-µm increments. After
collecting recordings, the CFM was removed and the CF-MEA-16 was implanted for recordings.
The mediolateral location of the CFM was approximately in the middle of the array. The
anteroposterior and dorsoventral locations of the CFM and CF-MEA-16 were also approximately
similar. Heat map (top) delineates [DA]max at recording sites and dorsoventral positions. Temporal
responses and associated voltammograms are shown for select locations in A1 to A4, designated
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by the corresponding number in the heat maps. Pseudocolor plots and individual voltammograms
are consistent with DA as the electrically evoked analyte. A3+4 overlays the recordings at location
3 of the CF-MEA-16 and location 4 of the CFM. The approximate anteroposterior, mediolateral,
and dorsoventral location of the CF-MEA-16 is shown in top left (Paxinos and Watson, 1986).
Hardware issues prevented recording at site 1 of the CF-MEA-16. Numbers and letter correspond
to location in the heat map. Horizontal lines underneath temporal responses demarcate the applied
stimulus train.
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Figure 17: Heterogeneity of electrically evoked 180-p DA signals in the striatum

Figure 17: Heterogeneity of electrically evoked 180-p DA signals in the striatum. A. DA
signals elicited by a 3-s (180-pulse) train were categorized into different types (Taylor et al., 2015).
Type 1 signals increase linearly during the pulse train. Type 2 signals also increase but not linearly.
No type 3 signals, for which the maximum is reached before the end of the stimulus train, were
recorded. Type 4 signals are biphasic. Slow signals exhibit an initial delay or lag in the DA increase
at the beginning of the pulse train. See Fig. 18B for [DA]max elicited by the 3-s pulse trains. The
approximate anteroposterior, mediolateral, and dorsoventral location of the CF-MEA-16 is shown
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at left. B. Representative recordings of the fast and slow types of evoked DA signals (left) are
shown with their initial increases expanded in time (right). Numbers and letter correspond to
location in the heat map. Blue boxes in temporal responses indicate stimulation on at 0-s (left and
right) and off at 3-s (left).
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Figure 18: Comparison of DA signals elicited by 0.4 and 3-s pulse trains

Figure 18. Comparison of DA signals elicited by 0.4- and 3-s pulse trains. A CF-MEA-16 was
implanted in the lateral aspect of the dorsomedial striatum of the anesthetized rat to record DA
signals electrically evoked by 0.4-s, 24-pulse and 3-s,180-pulse trains (A and B, respectively).
Calculated [DA]max is plotted as heat maps. Underneath the heat map for DA signals elicited by
0.4-s trains (A) are representative temporal responses and associated voltammograms for select
sites designated A1 to A5, corresponding to numbered sites in the heat map. Horizontal red lines
demarcate the stimulus train. Recordings analyzed for B were used to identify the type of DA
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signal described in Figure 17. C shows [DA]max (left y axis) and the number of sites without
detectable DA when elicited by a 0.4-s train (right y axis) for each type of DA signal. [DA]max is
expressed as the mean±SEM. Signal type is color coded according to Figure 17.
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Figure 19: Sensor Stability and Dynamic Range

Figure 19: Sensor Stability and Dynamic Range. A. [DA]max elicited by a 0.4-s train and
recorded by the CF-MEA-16 at a fixed location is stable over time. Trials were separated by 5 min.
B. [DA]max increases with the number of stimulus pulses. Stimulus trains consisted of 24, 36, 48,
60, 72, and 84 pulses, and measurements were collected at a fixed location of the CF-MEA-16.
Hardware issues prevented recording at site 1 of the CF-MEA-16.
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Figure 20: Comparison of in vivo SNR for monitoring DA signals
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Figure 20: Comparison of in vivo SNR for monitoring DA signals. SNR was determined for
the electrically evoked DA signals shown in Figures 16A and 18A and plotted as heat maps (A.
and B. top, respectively). Hardware issues system prevented recording at site 1 of the CF-MEA16 in A. Sensors of different types were not implanted at the same time; thus, CFM and array
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recordings were not simultaneously recorded. In A, the CFM was implanted first, measured DA,
and then withdrawn. The array was then implanted to approximately the same dorsoventral,
mediolateral, and anteroposterior position of the CFM. Positioning was similar in B, except that
three CFMs were simultaneously implanted. The approximate mediolateral location of the CFM
in A is the middle of the CF-MEA-16 at sites 7 to 9 (top and bottom left). The approximate
mediolateral location of the second CFM in B is the middle of the CF-MEA-16 at sites 9 to 10 (top
and bottom left). The first and third CFMs were located 1.2 mm mediolaterally to either side of the
second CFM and recorded DA signals in striatal subregions spatially beyond monitoring by the
CF-MEA-16 (bottom left). Recordings at all three CFM were collected simultaneously. The bar
graph at bottom right compares SNR for the CFM in A and middle CFM in B with the three middle
sites of each respective CF-MEA-16. SNR was averaged across dorsoventral position for both
CFM and CF-MEA-16. However, SNR was first averaged across the three middle sites of each
array canvassing the approximate mediolateral location of the CFM. T-tests failed to find a
significant difference in SNR between the array and CFM in A (t22 = 1.378; p = 0.18) and B (t18 =
0.7413; p = 0.47).
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Figure 21: AMPH modulated electrically evoked transient-like DA signals in the striatum
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Figure 21. AMPH modulates electrically evoked transient-like DA signals in the striatum. A.
Transient-like DA signals electrically evoked by a 0.4-s train were measured in the striatum of the
urethane-anesthetized rat by a CF-MEA-16. The location of these recordings is the lowest
dorsoventral position in Figure 2A. Pre- and post-AMPH recordings are shown to left and right,
respectively. Top temporal responses are the raw FSCV recording (solid blue line), raw FSCV
recording with the hang-up removed (gray dotted line), and the simulated response calculated from
parameters derived from model fitting of the recording with hang-up removed (dashed black line).
Horizontal red lines underneath temporal responses demarcate the applied stimulus train. The raw
FSCV recording is current measured at the peak oxidative potential for DA (horizontal blue line
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in pseudocolor plot underneath) and converted to concentration. See Figure 1 for details of the
pseudocolor plot. The hang-up removed from the raw FSCV response is attributed to DA
adsorption to the carbon fiber (Walters et al., 2015). Bottom recordings show simultaneously
recorded temporal responses and the associated portion of the pseudocolor plot for the applied
potential (+0.28 to 0.96 V) canvasing DA oxidation for pre (left)- and post (right)-AMPH
conditions. Dashed lines represent current measured at the peak oxidative potential for DA, which
is then converted to concentration for temporal responses. All recordings for site 9 are in blue.
Hardware issues prevented recording at site 1 of the CF-MEA-16. B. Heat maps show, from top
to bottom, [DA]max, Rp, kU, and kT for pre- and post-AMPH conditions. Δ and Δ % are absolute
and percentage change, respectively, from pre- to post-AMPH recordings.

96

Figure 22: AMPH elicits tonic and phasic DA signals
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Figure 22. AMPH elicits tonic and phasic DA signals. Non-electrically evoked DA signals are
shown for baseline (pre-drug) (A), post-AMPH (B and C), and post-AMPH and raclopride (D and
E). Top shows raw FSCV recordings converted to DA concentration and the corresponding
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pseudocolor plots and individual background-subtracted cyclic voltammograms underneath. See
Figure. 1 for details. Bottom shows simultaneously recorded, PCR-resolved temporal responses
for DA from 15 sites of the CF-MEA-16 (left) with the associated portions of the pseudocolor plot
for the applied potential (+0.28 to 0.96 V) canvasing DA oxidation (right). Blue lines identify
recording sites for temporal responses show above (top). Asterisks denote DA transients identified
by analysis of PCR-resolved recordings with peak-finding software. A. There is no evidence of
changes in DA during these pre-drug recordings collected five minutes before AMPH
administration. B. Recordings were collected three minutes after AMPH (1.0-mg/kg i.v.)
administration. All 15 sites of the CF-MEA-16 simultaneously recorded DA transients. C.
Recordings were collected six minutes after AMPH (1.0-mg/kg i.v.) administration. Not all sites
of the CF-MEA-16 recorded DA transients. Hardware issues prevented recording at site 1 of the
CF-MEA-16 in A, B, and C. D. Recordings were collected two minutes after i.p. administration
of AMPH (10 mg/kg) and raclopride (2 mg/kg). All sites show an increase in DA baseline,
although to varying degrees. Top plot of temporal response additionally shows the corresponding
Q-values (gray line) for the PCR analysis of the raw FSCV recording. All Q-values were below
Qα (18.7; dashed gray line), indicating a successful PCR. Top pseudocolor plot shows an additional
background-subtracted cyclic voltammogram collected at this CF-MEA-16 site from an
electrically evoked signal (dashed black line). This voltammogram serves as a DA reference to
highlight the DA component of the raw FSCV recording. While DA peaks are evident in the
voltammogram, other features are as well. These later interferents are removed by PCR to reveal
the DA component. E. Recordings were collected 50 minutes after i.p. administration of AMPH
(10 mg/kg) and raclopride (2 mg/kg). Not all sites show an increase in DA baseline.
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